Pharmavite completed the acquisition of Bonafide Health for $425m.

Pharmavite, a vitamin and supplement company, completed the acquisition of Bonafide Health, a women’s health company creating a new standard in managing the journey of menopause, for $425m. “We’re thrilled to welcome Bonafide Health to Pharmavite. This acquisition positions us as the nation’s leading women’s health nutraceutical company, signaling a new era of innovation and science-based solutions in this underserved space. Bonafide’s unwavering commitment to research, development, and robust scientific evidence mirrors Pharmavite’s rigorous standards, while its deep relationship with healthcare professionals aligns with our goal of ensuring nutrition education is at the forefront of the industry," Jeff Boutelle, Pharmavite CEO.